Evidence map›Paper›PMID 39273352›Full record

ArticleInternational journal of molecular sciences2024

Analytical Investigation of the Profile of Human Chorionic Gonadotropin in Highly Purified Human Menopausal Gonadotrophin Preparations.

Angela Capolupo, Sofia Petrocchi, Maura Melchiorre, Kim Jonas, Thomas D'Hooghe, Aylin Hanyaloglu, Sesh Sunkara, Angelo Palmese, Beste Ozgumus, Angela Amoresano and 4 more

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Angela CapolupoCharacterization & Innovative Analytics Unit-Analytical Development Biotech-Global Analytical Development-Global Development & Launch-Global Healthcare Operation, Merck Serono S.p.A., 00012 Guidonia, Italy, an affiliate of Merck KGaA, Darmstadt, Germany.
Sofia PetrocchiCharacterization & Innovative Analytics Unit-Analytical Development Biotech-Global Analytical Development-Global Development & Launch-Global Healthcare Operation, Merck Serono S.p.A., 00012 Guidonia, Italy, an affiliate of Merck KGaA, Darmstadt, Germany.
Maura MelchiorreCharacterization & Innovative Analytics Unit-Analytical Development Biotech-Global Analytical Development-Global Development & Launch-Global Healthcare Operation, Merck Serono S.p.A., 00012 Guidonia, Italy, an affiliate of Merck KGaA, Darmstadt, Germany.
Kim JonasDepartment of Women and Children's Health, School of Life Course and Population Health Sciences, King's College London, London WC2R 2LS, UK.
Thomas D'HoogheGlobal Medical Affairs-Fertility, Merck KGaA, 64293 Darmstadt, Germany.
Aylin HanyalogluDepartment of Metabolism, Digestion and Reproduction, Imperial College, London SW7 2AZ, UK.ORCID 0000-0003-4206-737X
Sesh SunkaraDepartment of Women and Children's Health, School of Life Course and Population Health Sciences, King's College London, London WC2R 2LS, UK.
Angelo PalmeseCharacterization & Innovative Analytics Unit-Analytical Development Biotech-Global Analytical Development-Global Development & Launch-Global Healthcare Operation, Merck Serono S.p.A., 00012 Guidonia, Italy, an affiliate of Merck KGaA, Darmstadt, Germany.
Beste OzgumusDepartment of Chemical Sciences, University of Naples Federico II, Via Cintia, 80126 Naples, Italy.ORCID 0009-0004-0899-7826
Angela AmoresanoDepartment of Chemical Sciences, University of Naples Federico II, Via Cintia, 80126 Naples, Italy.
Gabriella AngiuoniCharacterization & Innovative Analytics Unit-Analytical Development Biotech-Global Analytical Development-Global Development & Launch-Global Healthcare Operation, Merck Serono S.p.A., 00012 Guidonia, Italy, an affiliate of Merck KGaA, Darmstadt, Germany.
Susana MontenegroGlobal Medical Affairs-Fertility, Merck KGaA, 64293 Darmstadt, Germany.ORCID 0000-0003-1220-410X
Patrizia SimoneCharacterization & Innovative Analytics Unit-Analytical Development Biotech-Global Analytical Development-Global Development & Launch-Global Healthcare Operation, Merck Serono S.p.A., 00012 Guidonia, Italy, an affiliate of Merck KGaA, Darmstadt, Germany.
Monica LispiGlobal Medical Affairs-Fertility, Merck KGaA, 64293 Darmstadt, Germany.ORCID 0000-0002-9920-3208

Funding

Merck KGaA, Darmstadt, Germany NA
6 · The paper itself

Abstract

Highly purified human menopausal gonadotropin (HP-hMG [Menopur

Indexed as

Chorionic GonadotropinMenotropinsChromatography, LiquidFemaleFollicle Stimulating HormoneGlycopeptidesGlycosylationHumansLuteinizing HormoneMenopauseOxidation-ReductionPolysaccharidesPostmenopauseTandem Mass SpectrometryChorionic GonadotropinFollicle Stimulating HormoneGlycopeptidesLuteinizing HormoneMenotropinsPolysaccharidesglycosylation profilinghighly purified human menopausal gonadotropinluteinizing hormoneplacental human chorionic gonadotropin

Identifiers

PMID39273352
PMCPMC11395176

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.